In the brain cancer, numerous genetic alterations such as gain-of-function mutations, genomic amplification, chromosomal rearrangements, and/or autocrine activation promote the anomalous oncogenic activation of protein kinases which causes an increase in the activity of the kinase itself. Here, WEE1 is linked to brain cancer.